Device Trial Radar · NCT07001007
SCAPIS 2 Cardio - Vibrometer Based Pulse Wave Analysis and CVD Risk Assessment
Last checked: Nov 20, 2026Latest source record: Jun 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,600
Planned (sponsor's estimate)
Start
Jul 1, 2024
Primary completion
Jun 2026
Study completion Jun 2026
Sponsor
- Lead sponsor
- HJN Sverige AB/Neko HealthNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 3, 2025
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 58 years, up to 72 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This clinical investigation will evaluate a novel contactless technology for assessing arterial stiffness and pulse wave characteristics and explore its potential in assessment of coronary artery disease, aortic stenosis and heart failure, in a population-based sample aged 58-72 years. It will be the first in clinical setting, pilot stage, observational investigation to evaluate the clinical safety, performance and diagnostic accuracy of Cardio P4, a laser-doppler vibrometry (LDV) and microwave radar-based device.
Conditions
- Coronary Arterial Disease (CAD)
- Arterial Stiffness
- Aortic Valve Disease
- Heart Failure
Interventions
Coronary Computer Tomography (CCTA)Diagnostic test
Use of standard equipment for usual care
Laser Doppler Vibrometry and single-lead ECGOther
Physiological data acquisition equipment
EchocardiographyDevice
GE Vivid E95
Pulse Wave VelocityDevice
Arteriograph, Tensiomed, Hungary
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area under receiver operating curve (ROC) to predict CAD-RADS ≥2Time frame: Typically within 2 months of enrolment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Danderyds Hospital, KFC - Hjärt-kärllaboratoriet
Stockholm, Sweden · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.